BiotechTube
Home/Precision BioSciences/John A. Kelly
JA

John A. Kelly

Chief Financial Officer

Precision BioSciences

Therapeutic Areas

Rare Genetic DiseasesInfectious DiseaseNeuromuscular

Precision BioSciences Pipeline

DrugIndicationPhase
PBGENE-HBVChronic Hepatitis B Virus (HBV) InfectionPhase 1/2
PBGENE-DMDDuchenne Muscular Dystrophy (DMD)Phase 1/2
Azer-cel (PBCAR0191)Multiple SclerosisPhase 1/2

Leadership Team at Precision BioSciences

MA
Michael Amoroso
Chief Executive Officer
DJ
Derek J. Jantz, Ph.D.
Chief Scientific Officer & Co-Founder
AG
Alexandra Glucksmann, Ph.D.
Chief Operating Officer
BD
Brendan D. Miller
General Counsel
BJ
B. Jefferson (Jeff) Smith, Ph.D.
SVP, Corporate Development & Strategy
MC
Matthew C. Kane
President & Chief Business Officer
View full Precision BioSciences profile